Cathalijne Post

Prevalence and Prognosis of Lynch Syndrome and Sporadic Mismatch Repair Deficiency in Endometrial Cancer

Cathalijne Post, Ellen Stelloo, Vincent T.H.B.M. Smit et al. · JNCI Journal of the National Cancer Institute · 2021 · 100 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Efficacy and safety of durvalumab with olaparib in metastatic or recurrent endometrial cancer (phase II DOMEC trial)

Cathalijne Post, Anneke M. Westermann, Ingrid Boere et al. · Gynecologic Oncology · 2022 · 49 citations · Full text

Medicine, Oncology, Pharmacology +15

Long-Term Toxicity and Health-Related Quality of Life After Adjuvant Chemoradiation Therapy or Radiation Therapy Alone for High-Risk Endometrial Cancer in the Randomized PORTEC-3 Trial

Cathalijne Post, Stephanie M. de Boer, Melanie Powell et al. · International Journal of Radiation Oncology*Biology*Physics · 2020 · 48 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): 10-year clinical outcomes and post-hoc analysis by molecular classification from a randomised phase 3 trial

Cathalijne Post, Stephanie M. de Boer, Melanie Powell et al. · The Lancet Oncology · 2025 · 29 citations · Full text

Medicine, Gynecology, Oncology +17

Patterns of re-irradiation for recurrent gliomas and validation of a prognostic score

Cathalijne Post, Miranda C.A. Kramer, Ernst J. Smid et al. · Radiotherapy and Oncology · 2018 · 26 citations · Full text

Medicine, Oncology, Radiation Oncology +14